Introduction
Actinomyces species are a gram-positive, non-acid fast anaerobic bacteria that exhibit branching filamentous growth (1) . The organism does not cross mucosal barriers unless there is tissue injury (2) . In the female genital tract up to 30% of Papanicolaou-stained (PAP) cervicovaginal smears of intrauterine device (IUD) users are positive for actinomyces-like organisms (ALOs) (2) (3) (4) . The rate is lower with the levonorgestrel-releasing device and increases with the duration of use (2, 5) . Although actinomyces have been recognized as a commensal of the vagina in women, most authors found non-IUD wearers to be actinomycesfree (6, 7) .
In symptomatic ALOs positive IUD users consistently IUD removal and antibiotic treatment are recommended (2, 8, 9) . The management of ALOs in the absence of significant symptoms however is difficult and controversial. Therapeutic recommendations range from observation and controlling for the appearance of symptoms to the removal of the device with or without antibiotic treatment (2, 8, (10) (11) (12) (13) .
No recommendations exist for the treatment of asymptomatic ALOs positive women, who need a routine exchange of their IUD after the approved lifespan. In our family planning clinic we used to remove the IUD during menstruation, performed a PAP smear 6 weeks later and inserted a new device if this smear was negative for ALOs. In accordance with many authors we found in all cases the PAP smear to be negative 6 weeks after IUD removal (14, 15) . However, although we spend a lot of time to instruct women for contraception during the two months interval without IUD several pregnancies occurred. Therefore we discussed the risks of the option to exchange the IUD immediately. Because pelvic actinomycotic abscess is rare we held the view that an immediate exchange or a shorter interval between removal and reinsertion should not put women on an increased risk, to develop pelvic actinomycosis, if disappearance of ALOs is checked by a PAP smear six weeks after reinsertion. From April 
Statistical Analysis
Fisher`s exact test was used to test the difference between incidence of ALOs in both groups.
Student's t-test was used for comparison of baseline parameters. The level of significance was set at a p-value ≤ 0.05. Baseline data are given as mean (SD). All analyses were performed by using the Statview 4.01 data analyses software (Abacus Concepts, Berkeley, CA, USA).
Results
During the follow-up period 461 IUD insertions were performed. Before exchange of the IUD 47 IUD carriers had ALOs positive smears and a device in situ for 5 years. Thirty-eight of these women wished an IUD reinsertion and obtained a follow-up smear 6 weeks after IUD exchange. Incidentally the number of women was identical in both intervention groups (n=19). The mean age of the participants did not differ between groups (direct exchange 37.9 In both groups all smears obtained 6 weeks after IUD exchange were negative for ALOs.
Follow-up data for both groups are presented in Table 1 . After 12-36 months there is a high rate of recolonisation with ALOs (table 1) . Although more ALOs positive cases were observed after three years in the group with direct exchange this difference is not statistically significant. The 36 months smear of one woman with a LNG-IUD was ALOs negative. After exchange of the IUD all ALOs positive smears persisted to be positive during the whole follow-up period.
Discussion
In the present study the incidence of ALOs reappearance after routine IUD exchange in ALOs positive women was investigated. The devices were inserted according to two clinical procedures. Both, IUD removal with immediate or interval refitting resulted in ALOs negative smears at the first cytological examination carried out after 6 weeks. At first sight this suggests, that immediate and interval IUD refitting is a good option for carriers of ALOs with need for a routine exchange. However, during longer follow-up we observed a trend to more ALOs positive smears in the group with direct IUD exchange, which increased with the duration of use (Table 1) . Although the recolonisation rate is not significantly different after 36 months, we suppose, that with longer follow-up the difference between groups might be relevant. The incidence of 73% ALOs positive smears three years after direct device exchange is very high in comparison with ML 375 users after interval exchange (33%), whereas the incidence after interval exchange is similar to that of users without a previous history of ALOs, which was reported to be 27% in our clinic after 36 months and 32.9% independent of duration of use.(5, 16) Other authors found a colonisation rate of 17% after 25-36 months of use, when inert and copper IUDs where included into the analysis(3). In carriers of the LNG-IUD the incidence of ALOs positive smears is extremely low with 2.9%. 5 Because in both groups only one person wished the insertion of an LNG-IUD, whereas all other women received a ML 375 device, variety in IUD-types between groups can not account for the distinct difference in ALOs recolonisation in the present study. However, before drawing clinical consequences of our results the following aspects have to be considered. Cytological diagnosis of actinomyces is difficult and the clinical significance of ALOs positive PAP smears is still uncertain (2, 7, 9, 17) . Several authors report a lack specificity of PAP smears in identifying actinomycetes (9, 18) . False -positive identification can occur in the presence of Candida, Lepthotrix, Aspergillus and Eubactrium nodatum (4, 19) . Therefore the term
ALOs is preferable to actinomyces in reporting a PAP smear (2) . ALOs positive smears reflect colonisation but not necessarily infection. Under ordinary conditions Actinomyces do not cross mucosal barriers (2) . However, if the mucosa is disrupted actinomycosis can result.
On the other hand the diagnosis of severe pelvic actinomycosis is often delayed, because symptoms are modest in relation to the extensive disease (4, 20) . An important strength of our study is the long observation period, which allowed us to recognise that in spite of the fact that 100% of the smears obtained after 6 weeks were ALOs negative, ALOs may reappear more often, if there is no interval between removal and reinsertion. Our results are limited by the high dropout rate. The most common reason for dropout was IUD dislocation, which occurred in seven cases during the first year after insertion. The dislocation rate was in the range reported previously for copper devices (21, 22) . The observation that most dislocations occurred during the first year is in accordance with data of other authors. (21, 22) .
In conclusion at the end of the lifespan immediate IUD exchange as well as removal and reinsertion after 3-5 days are sufficient to eliminate ALOs. The rate of ALOs reoccurrence may be higher with immediate exchange. Both procedures are more safe and convenient than a 6 week IUD-free interval.
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